Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus

Current Opinion in Pharmacology

Volumn 12, Issue 2, 2012, Pages 134-141

  Aronson, Doron ^a   Edelman, Elazer R ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

ACUTE KIDNEY FAILURE; ARTICLE; BARE METAL STENT; BONE INFECTION; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; DRUG SAFETY; GLYCEMIC CONTROL; GRAFT FAILURE; GRAFT PATENCY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; STERNUM; STROKE; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; WOUND COMPLICATION;

EID: 84861700096     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.01.011     Document Type: Review

References (58)

1. G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, C.J. Paciorek, J.K. Lin, F. Farzadfar, Y.H. Khang, and G.A. Stevens National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 2011 31 40
2. J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 2010 4 14
3. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32 Suppl. 1:S62-S67.
4. D.M. Maahs, N.A. West, J.M. Lawrence, and E.J. Mayer-Davis Epidemiology of type 1 diabetes Endocrinol Metab Clin North Am 39 2010 481 497
5. C. Berry, J.C. Tardif, and M.G. Bourassa Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization J Am Coll Cardiol 49 2007 643 656
6. C. Berry, J.C. Tardif, and M.G. Bourassa Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management J Am Coll Cardiol 49 2007 631 642
7. A. Kapur, R. Hall, I. Malik, A. Qureshi, J. Butts, M. de Belder, A. Baumbach, G. Angelini, A. de Belder, and K. Oldroyd Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) Trial J Am Coll Cardiol 55 2010 432 440
8. D. Aronson, Z. Bloomgarden, and E.J. Rayfield Potential mechanisms promoting restenosis in diabetic patients J Am Coll Cardiol 27 1996 528 535
9. D. Aronson, and E.R. Edelman Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting Rev Endocr Metab Disord 11 2010 75 86
10. G.W. Stone, E. Kedhi, D.J. Kereiakes, H. Parise, M. Fahy, P.W. Serruys, and P.C. Smits Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus Circulation 124 2011 893 900
11. M. Roffi, D.J. Angiolillo, and A.P. Kappetein Current concepts on coronary revascularization in diabetic patients Eur Heart J 32 2011 2748 2757
12. X. Zhang, Z. Wu, X. Peng, A. Wu, Y. Yue, J. Martin, and D. Cheng Prognosis of diabetic patients undergoing coronary artery bypass surgery compared with nondiabetics: a systematic review and meta-analysis J Cardiothorac Vasc Anesth 25 2011 288 298
13. G.R. Dagenais, J. Lu, D.P. Faxon, K. Kent, R.M. Lago, C. Lezama, W. Hueb, M. Weiss, J. Slater, and R.L. Frye Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease Circulation 123 2011 1492 1500
14. R.L. Frye, P. August, M.M. Brooks, R.M. Hardison, S.F. Kelsey, J.M. MacGregor, T.J. Orchard, B.R. Chaitman, S.M. Genuth, and S.H. Goldberg A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
15. D.J. Maron, W.E. Boden, J.A. Spertus, P.M. Hartigan, G.B. Mancini, S.P. Sedlis, W.J. Kostuk, B.R. Chaitman, L.J. Shaw, and D.S. Berman Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial J Am Coll Cardiol 58 2011 131 137
16. The Bypass Angioplasty Revascularization Investigation (BARI) Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease [see comments] Circulation 96 1997 1761 1769
17. The BARI Investigators: The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007, 49:1600-1606.
18. M.A. Hlatky, D.B. Boothroyd, D.M. Bravata, E. Boersma, J. Booth, M.M. Brooks, D. Carrie, T.C. Clayton, N. Danchin, and M. Flather Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Lancet 373 2009 1190 1197
19. A.P. Banning, S. Westaby, M.C. Morice, A.P. Kappetein, F.W. Mohr, S. Berti, M. Glauber, M.A. Kellett, R.S. Kramer, and K. Leadley Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents J Am Coll Cardiol 55 2010 1067 1075
20. A.P. Kappetein, T.E. Feldman, M.J. Mack, M.C. Morice, D.R. Holmes, E. Stahle, K.D. Dawkins, F.W. Mohr, P.W. Serruys, and A. Colombo Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
21. Y. Onuma, J.J. Wykrzykowska, S. Garg, P. Vranckx, and P.W. Serruys 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials JACC Cardiovasc Interv 4 2011 317 323
22. D.W. Park, Y.H. Kim, H.G. Song, J.M. Ahn, J. Oh, W.J. Kim, J.Y. Lee, S.J. Kang, S.W. Lee, and C.W. Lee Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry J Am Coll Cardiol 57 2011 128 137
23. M. Mack Does percutaneous coronary intervention compromise the outcome of subsequent coronary artery bypass grafting? JACC Cardiovasc Interv 2 2009 765 766
24. S. Chocron, R. Baillot, J.L. Rouleau, W.J. Warnica, P. Block, D. Johnstone, M.G. Myers, C.D. Calciu, A. Nozza, and P. Martineau Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study Eur Heart J 29 2008 673 679
25. K.M. Detre, M.S. Lombardero, M.M. Brooks, R.M. Hardison, R. Holubkov, G. Sopko, R.L. Frye, and B.R. Chaitman The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators N Engl J Med 342 2000 989 997
26. L. Schwartz, K.E. Kip, R.L. Frye, E.L. Alderman, H.V. Schaff, and K.M. Detre Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI) Circulation 106 2002 2652 2658
27. H.Y. Hwang, J.S. Choi, and K.B. Kim Diabetes does not affect long-term results after total arterial off-pump coronary revascularization Ann Thorac Surg 90 2010 1180 1186
28. K.E. Kip, E.L. Alderman, M.G. Bourassa, M.M. Brooks, L. Schwartz, D.R. Holmes Jr., R.M. Califf, P.L. Whitlow, B.R. Chaitman, and K.M. Detre Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation Circulation 105 2002 1914 1920
29. T. Kinoshita, T. Asai, O. Nishimura, T. Suzuki, A. Kambara, and K. Matsubayashi Off-pump bilateral versus single skeletonized internal thoracic artery grafting in patients with diabetes Ann Thorac Surg 90 2010 1173 1179
30. D. Pevni, G. Uretzky, A. Mohr, R. Braunstein, A. Kramer, Y. Paz, I. Shapira, and R. Mohr Routine use of bilateral skeletonized internal thoracic artery grafting: long-term results Circulation 118 2008 705 712
31. J. Nakano, H. Okabayashi, M. Hanyu, Y. Soga, T. Nomoto, Y. Arai, T. Matsuo, M. Kai, and M. Kawatou Risk factors for wound infection after off-pump coronary artery bypass grafting: should bilateral internal thoracic arteries be harvested in patients with diabetes? J Thorac Cardiovasc Surg 135 2008 540 545
32. S. Saso, D. James, J.A. Vecht, E. Kidher, J. Kokotsakis, V. Malinovski, C. Rao, A. Darzi, J.R. Anderson, and T. Athanasiou Effect of skeletonization of the internal thoracic artery for coronary revascularization on the incidence of sternal wound infection Ann Thorac Surg 89 2010 661 670
33. T. Kinoshita, T. Asai, T. Suzuki, A. Kambara, and K. Matsubayashi Off-pump bilateral versus single skeletonized internal thoracic artery grafting in high-risk patients Circulation 124 2011 S130 S134
34. B.P. Choudhary, C. Antoniades, A.F. Brading, A. Galione, K. Channon, and D.P. Taggart Diabetes mellitus as a predictor for radial artery vasoreactivity in patients undergoing coronary artery bypass grafting J Am Coll Cardiol 50 2007 1047 1053
35. S. Goldman, G.K. Sethi, W. Holman, H. Thai, E. McFalls, H.B. Ward, R.F. Kelly, B. Rhenman, G.H. Tobler, and F.G. Bakaeen Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial JAMA 305 2011 167 174
36. P. Knapik, P. Nadziakiewicz, E. Urbanska, W. Saucha, M. Herdynska, and M. Zembala Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery Ann Thorac Surg 87 2009 1859 1865
37. H.L. Lazar, M. McDonnell, S.R. Chipkin, A.P. Furnary, R.M. Engelman, A.R. Sadhu, C.R. Bridges, C.K. Haan, R. Svedjeholm, and H. Taegtmeyer The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery Ann Thorac Surg 87 2009 663 669
38. G.Y. Gandhi, G.A. Nuttall, M.D. Abel, C.J. Mullany, H.V. Schaff, P.C. O'Brien, M.G. Johnson, A.R. Williams, S.M. Cutshall, and L.M. Mundy Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial Ann Intern Med 146 2007 233 243
39. D.E. Griesdale, R.J. de Souza, R.M. van Dam, D.K. Heyland, D.J. Cook, A. Malhotra, R. Dhaliwal, W.R. Henderson, D.R. Chittock, and S. Finfer Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data CMAJ 180 2009 821 827 discussion 799-800
40. S. Finfer, D.R. Chittock, S.Y. Su, D. Blair, D. Foster, V. Dhingra, R. Bellomo, D. Cook, P. Dodek, and W.R. Henderson Intensive versus conventional glucose control in critically ill patients N Engl J Med 360 2009 1283 1297
41. G. D'Ancona, F. Bertuzzi, L. Sacchi, F. Pirone, V. Stringi, A. Arcadipane, R. Bellazzi, and M. Pilato Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity Eur J Cardiothorac Surg 40 2011 360 366
42. N. Yakubovich, and H.C. Gerstein Serious cardiovascular outcomes in diabetes Circulation 123 2011 342 348
43. O. Rana, C.D. Byrne, D. Kerr, D.V. Coppini, S. Zouwail, R. Senior, J. Begley, J.J. Walker, and K. Greaves Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans Circulation 124 2011 1548 1556
44. C.M. Bhamidipati, D.J. LaPar, G.J. Stukenborg, C.C. Morrison, J.A. Kern, I.L. Kron, and G. Ailawadi Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting J Thorac Cardiovasc Surg 141 2011 543 551
45. E.S. Moghissi, M.T. Korytkowski, M. DiNardo, D. Einhorn, R. Hellman, I.B. Hirsch, S.E. Inzucchi, F. Ismail-Beigi, M.S. Kirkman, and G.E. Umpierrez American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control Diabetes Care 32 2009 1119 1131
46. A. Qaseem, L.L. Humphrey, R. Chou, V. Snow, and P. Shekelle Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians Ann Intern Med 154 2011 260 267
47. A.B. Goldfine, and V. Fonseca Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Circulation 121 2010 2447 2449
48. D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, R. Sherwin, B. Zinman, American Diabetes A, and European Association for Study of D Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 2009 193 203
49. S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2007 2457 2471
50. L.A. Nikolaidis, S. Mankad, G.G. Sokos, G. Miske, A. Shah, D. Elahi, and R.P. Shannon Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 2004 962 965
51. G.G. Sokos, H. Bolukoglu, J. German, T. Hentosz, G.J. Magovern Jr., T.D. Maher, D.A. Dean, S.H. Bailey, G. Marrone, and D.H. Benckart Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting Am J Cardiol 100 2007 824 829
52. R. De Caterina, R. Madonna, H. Sourij, and T. Wascher Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options Eur Heart J 31 2010 1557 1564
53. L.H. Young, F.J. Wackers, D.A. Chyun, J.A. Davey, E.J. Barrett, R. Taillefer, G.V. Heller, A.E. Iskandrian, S.D. Wittlin, and N. Filipchuk Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial JAMA 301 2009 1547 1555
54. B.R. Chaitman, R.M. Hardison, D. Adler, S. Gebhart, M. Grogan, S. Ocampo, G. Sopko, J.A. Ramires, D. Schneider, and R.L. Frye The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction Circulation 120 2009 2529 2540
55. M.R. Patel, G.J. Dehmer, J.W. Hirshfeld, P.K. Smith, and J.A. Spertus ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography J Am Coll Cardiol 53 2009 530 553
56. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, and J. Knuuti Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
57. B. Marcheix, F. Vanden Eynden, P. Demers, D. Bouchard, and R. Cartier Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery Ann Thorac Surg 86 2008 1181 1188
58. A.H. van Straten, M.A. Hamad, A.A. van Zundert, E.J. Martens, J.P. Schonberger, and A.M. de Wolf Risk factors for deterioration of renal function after coronary artery bypass grafting Eur J Cardiothorac Surg 37 2010 106 111